MetaCap

Cronos Group (CRON) vs MediWound (MDWD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cronos Group (CRON) has outperformed MediWound (MDWD) over the past year, gaining 28.3% versus a loss of 20.3%. Over five years, MDWD leads with a -25.0% price change compared with -34.9% for CRON. Cronos Group is the larger company by market cap ($1.11 billion vs $195.6 million), about 5.7 times the size.

Cronos Group converts more of its revenue into profit, with a net margin of -6.4% versus -140.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CRON+28.27%MDWD-20.34%
+61%+13%-35%
Nov 21, 20251 yearNov 20, 2026
CRON-38.34%MDWD-32.35%
+13%-28%-70%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CRON versus MDWD key metrics
MetricCRONMDWD
Share price$3.04$13.59
Market cap$1.11B$195.56M
1-day change-1.30%+0.37%
YTD return+15.59%-26.38%
1-year return+28.27%-20.34%
5-year return-34.90%-25.04%
P/E ratio (TTM)19.00—
EPS (TTM)$0.16$-2.59
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$146.59M$16.96M
Revenue growth (YoY)+24.63%-16.14%
Net income (latest FY)$-9.45M$-23.88M
Gross margin42.81%19.19%
Operating margin-11.87%-148.98%
Net margin-6.44%-140.80%
52-week high$3.91$19.70
52-week low$2.35$11.80
Distance from 52-week high-22.25%-31.02%
Analyst consensusstrong_buystrong_buy
Avg. price target upside-3.62%+118.32%
Average volume1.07M125.80K
Shares outstanding366.47M14.39M
Employees610121
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cronos Group is about 5.7 times larger than MediWound by market value ($1.11B vs $195.56M).
  • CRON has outperformed MDWD by 48.6 percentage points over the past year.
  • Cronos Group is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -140.8 cents for MediWound.
  • Cronos Group grew revenue faster in its latest fiscal year (+24.63% vs -16.14%).

About Cronos Group

CRON stock →

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.

Health Care · Medicinal Chemicals and Botanical Products · 610 employees

About MediWound

MDWD stock →

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

Health Care · Medicinal Chemicals and Botanical Products · 121 employees

CRON vs MDWD FAQ

Which is bigger, Cronos Group or MediWound?

Cronos Group (CRON) is larger, with a market capitalization of $1.11B compared with $195.56M for MediWound (MDWD).

Which stock has performed better over the past year, CRON or MDWD?

CRON returned +28.27% over the past 12 months, compared with -20.34% for MDWD (price return, excluding dividends). Past performance does not predict future results.

Are Cronos Group and MediWound in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons